Chen Schor - 19 May 2021 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
President & CEO, Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
19 May 2021
Net transactions value
-$221,436
Form type
4
Filing time
21 May 2021, 16:34:09 UTC
Previous filing
07 May 2021
Next filing
21 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale $92,244 -6,872 -7.1% $13.42 90,421 19 May 2021 See Footnote F1, F2, F3
transaction ACET Common Stock Sale $8,401 -612 -0.68% $13.73 89,809 19 May 2021 See Footnote F1, F3, F4
transaction ACET Common Stock Sale $110,728 -8,249 -7.1% $13.42 108,533 19 May 2021 See Footnote F1, F2, F5
transaction ACET Common Stock Sale $10,062 -733 -0.68% $13.73 107,800 19 May 2021 See Footnote F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.69 to $13.66, inclusive.
F3 Represents shares held directly by an irrevocable family trust having an independent trustee.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.69 to $13.79, inclusive.
F5 Represents shares held directly by an irrevocable family trust having an independent trustee.